Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
1 selected
)
Type
Guidance (1898)
NICE advice (321)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (225)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (603)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (341)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (791)
Apply filters
Showing 551 to 600 of 1898
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
TA725
15 September 2021
15 September 2021
Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancer
TA724
8 September 2021
8 September 2021
Bimekizumab for treating moderate to severe plaque psoriasis
TA723
1 September 2021
1 September 2021
Pemigatinib for treating relapsed or refractory advanced cholangiocarcinoma with FGFR2 fusion or rearrangement
TA722
25 August 2021
25 August 2021
Magnetic resonance therapy for knee osteoarthritis
IPG702
25 August 2021
25 August 2021
Laparoscopic removal of uterine fibroids with power morcellation
IPG703
25 August 2021
25 August 2021
Hysteroscopic mechanical tissue removal (hysteroscopic morcellation) for uterine fibroids
IPG704
25 August 2021
25 August 2021
Babies, children and young people's experience of healthcare
NG204
25 August 2021
25 August 2021
Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome
TA139
26 March 2008
20 August 2021
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s
NG202
20 August 2021
20 August 2021
Antenatal care
NG201
19 August 2021
19 August 2021
Chlormethine gel for treating mycosis fungoides-type cutaneous T-cell lymphoma
TA720
18 August 2021
18 August 2021
Abiraterone for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancer
TA721
18 August 2021
18 August 2021
Bronchiolitis in children: diagnosis and management
NG9
1 June 2015
9 August 2021
Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency
TA716
28 July 2021
28 July 2021
Inducing and maintaining normothermia using temperature modulation devices to improve outcomes after stroke or subarachnoid haemorrhage
IPG701
28 July 2021
28 July 2021
Clostridioides difficile infection: antimicrobial prescribing
NG199
23 July 2021
23 July 2021
Duvelisib for treating relapsed follicular lymphoma after 2 or more systemic therapies (terminated appraisal)
TA717
21 July 2021
21 July 2021
Ixekizumab for treating axial spondyloarthritis
TA718
21 July 2021
21 July 2021
Secukinumab for treating non-radiographic axial spondyloarthritis
TA719
21 July 2021
21 July 2021
ENDURALIFE powered CRT-D devices for treating heart failure
MTG33
17 March 2017
21 July 2021
Dasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia (terminated appraisal)
TA714
14 July 2021
14 July 2021
Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failed
TA715
14 July 2021
14 July 2021
Enzalutamide for treating hormone-sensitive metastatic prostate cancer
TA712
7 July 2021
7 July 2021
Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapy
TA713
7 July 2021
7 July 2021
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation
TA249
15 March 2012
2 July 2021
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation
TA256
23 May 2012
2 July 2021
Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation
TA355
23 September 2015
2 July 2021
Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation
TA275
27 February 2013
2 July 2021
Atrial fibrillation: diagnosis and management
NG196
27 April 2021
30 June 2021
Plus Sutures for preventing surgical site infection
MTG59
28 June 2021
28 June 2021
Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitis
TA708
23 June 2021
23 June 2021
Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency
TA709
23 June 2021
23 June 2021
Ravulizumab for treating atypical haemolytic uraemic syndrome
TA710
23 June 2021
23 June 2021
Laser lithotripsy for difficult-to-treat bile duct stones
IPG699
23 June 2021
23 June 2021
Percutaneous insertion of a closure device to repair a paravalvular leak around a replaced mitral or aortic valve
IPG700
23 June 2021
23 June 2021
Patient experience in adult NHS services: improving the experience of care for people using adult NHS services
CG138
24 February 2012
17 June 2021
Shared decision making
NG197
17 June 2021
17 June 2021
Nivolumab for previously treated unresectable advanced or recurrent oesophageal cancer
TA707
15 June 2021
15 June 2021
Autism spectrum disorder in adults: diagnosis and management
CG142
27 June 2012
14 June 2021
Autism spectrum disorder in under 19s: support and management
CG170
28 August 2013
14 June 2021
Ozanimod for treating relapsing–remitting multiple sclerosis
TA706
9 June 2021
9 June 2021
Atezolizumab monotherapy for untreated advanced non-small-cell lung cancer
TA705
2 June 2021
2 June 2021
Ibrutinib with obinutuzumab for untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (terminated appraisal)
TA702
26 May 2021
26 May 2021
Ibrutinib with rituximab for untreated chronic lymphocytic leukaemia (terminated appraisal)
TA703
26 May 2021
26 May 2021
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapies
TA704
26 May 2021
26 May 2021
Electrohydraulic lithotripsy for difficult-to-treat bile duct stones
IPG698
26 May 2021
26 May 2021
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex-vivo lung perfusion) for transplant
IPG695
26 May 2021
26 May 2021
Transvaginal laser therapy for stress urinary incontinence
IPG696
26 May 2021
26 May 2021
Transvaginal laser therapy for urogenital atrophy
IPG697
26 May 2021
26 May 2021
Previous page
1
…
10
11
Current page
12
13
14
…
38
Page
12
of
38
Next page
Results per page
10
25
50
All
Back to top